☆ 4.3 Editorial Material

MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway

JOURNAL OF THORACIC DISEASE (2018)

Get Full Text
Add to Collection

Journal

JOURNAL OF THORACIC DISEASE
Volume 10, Issue -, Pages S2076-S2078

Publisher

AME PUBLISHING COMPANY
DOI: 10.21037/jtd.2018.04.122

Keywords

-

Categories

Respiratory System

Funding

  1. Brazilian National Development Council for Science and Technology (CNPQ) [402621/2016-6]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.